DDX27 and gastric cancer: Zhou et al. found that DDX27 knockdown sensitized the gastric cancer cells to epirubicin or cisplatin, and conversely its overexpression reduced the eirenicon-induced DNA damage and apoptosis (Zhou et al., 2015).